Assessment of Esophageal Epithelium Integrity With Use of a Novel Mucosal Impedance Device

StatusEnrolling by Invitation
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Aug 31, 2026 → Aug 31, 2027
See other at-risk trials from Vanderbilt University Medical Center

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Aug 31, 2026 to Aug 31, 2027
    • Publications: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 5 words
  2. Re-verified, no change to tracked fieldsv12
  3. Primary and study completion dates: Aug 31, 2025 to Aug 31, 2026v11
  4. Primary and study completion dates: Aug 31, 2024 to Aug 31, 2025v10
  5. Re-verified, no change to tracked fieldsv9
Show 7 earlier versionsHide 7 earlier versions
  1. Primary and study completion dates: Aug 31, 2022 to Aug 31, 2024v8
  2. Re-verified, no change to tracked fieldsv7
  3. Primary and study completion dates: Aug 31, 2020 to Aug 31, 2022v6
  4. Re-verified, no change to tracked fieldsv5
  5. Primary and study completion dates: Aug 31, 2019 to Aug 31, 2020v4
  6. Primary and study completion dates: Aug 31, 2018 to Aug 31, 2019v3
  7. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
The objective of this study is to design and use a novel, minimally invasive mucosal impedance (MI) technology to inexpensively and accurately test mucosal health in suspected gastroesophageal reflux disease (GERD) and nonerosive reflux disease (NERD) patients as compared to those without GERD.
Trial Details
NCT Number NCT03103789
Lead Sponsor Vanderbilt University Medical Center
Collaborators: Sandhill Scientific
Conditions
(from sponsor)		 Gastro Esophageal Reflux
Related terms Gastroesophageal Reflux
Enrollment 75 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov